A multicenter randomized controlled clinical study of Chuanhuang prescription combined with reduced glutathione regimen in the treatment of patients with 1-2 grade AKI on the basis of 2-4 stage CKD and its clinical evaluation of early diagnostic markers
- Conditions
- A on C
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. It meets the diagnostic criteria of stage CKD2-4 and stage 1-2 of acute kidney injury;
2. Meet the criteria for TCM syndrome diagnosis of deficiency of spleen and kidney and mutual knot of toxin and blood stasis;
3. 24 hU - pro 2.5 grams or less;
4. Aged between 18 and 75;
5. Patients who voluntarily participate in this clinical trial and sign the informed consent.
1. pregnancy or preparation for pregnancy and breast-feeding women;
2. complicated with serious primary diseases with other organs in urgent need of immediate treatment, or with malignant tumors, active tuberculosis and other consumption system diseases;
3. after renal transplantation;
4. mentally ill, unable to cooperate;
5. allergic to therapeutic drugs;
6. participants in other drug clinical trials or in other clinical trials within 3 months.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method